Deficiency in systemic interleukin-1 receptor antagonist production as an operative risk factor in malnourished elderly patients with colorectal carcinoma

Critical Care Medicine

Volumn 33, Issue 1, 2005, Pages 177-180

  Miki, Chikao ^a   Inoue, Yasuhiro ^a   Toiyama, Yuji ^a   Ojima, Eiki ^a   Kobayashi, Minako ^a   Hatada, Tsuyoshi ^a   Araki, Toshimitsu ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aged patient; Colorectal carcinoma; Cytokine response; Postoperative complication; Risk factor; Surgery

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6;

AGED; ARTICLE; BLEEDING; BODY MASS; BODY WEIGHT; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOREACTIVITY; INTRAOPERATIVE PERIOD; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEUTROPHIL; NUTRITIONAL STATUS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE INFLAMMATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL RISK;

AGE FACTORS; AGED; BODY MASS INDEX; COLECTOMY; COLON, SIGMOID; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROTEIN-ENERGY MALNUTRITION; RECEPTORS, INTERLEUKIN-6; RISK FACTORS; SIALOGLYCOPROTEINS; SURGICAL WOUND INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 12244283720     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000150661.69565.D8     Document Type: Article

References (21)

1. Koperna T, Kisser M, Schulz F: Emergency surgery for colon cancer in the aged. Arch Surg 1997; 132:1032-1037
2. Davydov IuA, Abramov AIu, Darichev AB: Regulation of wound process by the method of vacuum therapy in middle-aged and aged patients. Khirurgiia 1994; 9:7-10
3. te Velthuis H, Jansen PG, Oudemans-van Straaten HM, et al: Myocardial performance in elderly patients after cardiopulmonary by-pass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg 1995; 110:1663-1669
4. Falconer JS, Fearon KC, Plester CE, et al: Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219:325-331
5. Staal-van den Brekel AJ, Dentener MA, Buurman WA, et al: Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995; 13:2600-2605
6. Eachempati SR, Hydo LJ, Barie PS: Factors influencing the development of decubitus ulcers in critically ill surgical patients. Crit Care Med 2001; 29:1678-1682
7. Geppert A, Steiner A, Zorn G, et al: Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 2002; 30:1987-1994
8. Rubinson L, Diette GB, Song X, et al: Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Crit Care Med 2004; 32:350-357
9. Hilska M, Collan Y, Roberts PJ, et al: Prognostic value of various staging and grading systems in proximal colon cancer. Eur J Surg 2002; 168:84-90
10. Bailey KV, Ferro-Luzzi A: Use of body mass index of adults in assessing individual and community nutritional status. Bull World Health Organ 1995; 73:673-680
11. Tilg H, Treh E, Atkins MB, et al: Interleukin-6 as an anti-inflammatory cytokine: Induction of circulating interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor p 55. Blood 1994; 83:113-118
12. Lu ZY, Bataille R, Poubelle P, et al: An interleukin-1 receptor antagonist blocks the il-1-induced il-6 paracrine production through a prostaglandin e2-related mechanism on multiple myeloma. Stem Cells 1995; 13:28-34
13. Luheshi G, Miller AJ, Brouwer S, et al: Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am J Physiol 1996; 270(Endocrinol Metab 33):E91-E95
14. Roubenoff R, Harris TB, Abrad LW, et al: Monocyte cytokine production in an elderly population: Effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998; 53:M20-M26
15. Ito H, Miki C: Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol 1999; 34:1139-1143
16. Ogawa M: Acute pancreatitis and cytokines: "Second attack" by septic complication leads to organ failure. Pancreas 1998; 16:312-315
17. Isoda K, Shiigai M, Ishigami N, et al: Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation. 2003 5;108:516-518
18. Norman J, Franz M, Messina J, et al: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995; 117:648-655
19. Tanaka N, Murata A, Uda K, et al: Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995; 23:901-908
20. Norman JG, Franz MG, Fink GS, et al: Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995; 221:625-631
21. Hawkins PN, Lachmann HJ, McDermott MF: Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003; 348:2583-2584